|

Inactivated hepatitis A vaccine (I-HAV) Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Chiang Mai University1

Indications

  • Hepatitis A Virus1
  • Liver Disease1
  • Hepatitis A1
  • Vaccine-Preventable Diseases1

Other1 trial

Immunogenicity and Safety of I-HAV in Healthy Thai Children and Adolescents Lacking Protective Antibody After L-HAV
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.